Table 1. Study demographics, ordered by study design and year of publication.
Authors | Continent | Year | Study type | Subtypes of repair technique | Total patients | Age in years (mean) | Sex (M:F) | Pathologies | Mean tumor size (mm) | BMI | Follow-up |
---|---|---|---|---|---|---|---|---|---|---|---|
Kalamarides et al 18 | Europe | 2004 | Prospective case series | 139 | NS | NS | VS | NS | NS | 1 y + | |
Sen et al 16 | Europe | 2006 | Prospective case series | 24 | 51 | 12 M:12 F | VS | NS | NS | NS | |
Moderie et al 17 | North America | 2017 | Prospective case series | 94 | 35.5 | 40 M:54 F | VS | 24.1 | NS | 2.1 y | |
Hillman and Shelton 15 | North America | 2011 | Prospective case series with matched cohort analysis | TL cavity: fat + resorbable plate | 71 | 51 | 34 M:37 F | n = 70 VS, n = 1 meningioma | 20 | NS | NS |
TL cavity: fat closure | 149 | 49.8 a | 68 M:81 F | n = 147 VS, n = 2 meningioma | 22 | NS | NS | ||||
Brennan et al 57 | North America | 2001 | Retrospective case series | 431 | NS | NS | VS | 21.3 | NS | NS | |
Leonetti et al 31 | North America | 2001 | Retrospective case series | 209 | 56.4 | 1 M: 1.18 F | VS 77%, meningioma 10%, paraganglioma 7%, other 6% | <1 cm 23%, 1.1–2.0 cm 17%, 2.1–3 cm 40%, >3 cm 20% | NS | NS | |
Arriaga and Chen 21 | North America | 2002 | Retrospective case series | AFG | 54 | NS | 26 M:28 F | VS | 22 | NS | 1 y+ |
HAC 1 (hardened cement contacts dura | 7 | NS | 24 M:30 F | VS | NS | ||||||
HAC 2 (fat contacts dura, then filled with HAC) | 47 | NS | |||||||||
Becker et al 10 | North America | 2003 | Retrospective case series | 100 | 51 | 50 M:50 F | VS | 22 | NS | NS | |
Sanna et al 32 | Europe | 2003 | Retrospective case series | 596 | NS | NS | VS | NS | NS | NS | |
Cueva and Mastrodimos 64 | North America | 2005 | Retrospective case series | 126 | NS | NS | VS | 20 | NS | NS | |
Hussain and Ahsan 46 | North America | 2005 | Retrospective case series | 20 | 54.4 | 7 M:3 F | VS | NS | 6 mo | ||
Arriaga et al 38 | North America | 2007 | Retrospective case series | 90 | NS | NS | 22 | ||||
Fayad et al 41 | North America | 2007 | Retrospective case series | 389 | 47.6 | 187 M: 202 F | VS | 24 | NS | NS | |
Jacob et al 19 | North America | 2007 | Retrospective case series | ET packing | 148 | NS | NS | NS | NS | NS | NS |
North America | 2007 | Retrospective case series | No ET packing | 51 | NS | NS | NS | NS | NS | NS | |
Roche et al 37 | Europe | 2008 | Retrospective case series | 110 | 50.1 | 44 M:66 F | VS | Stage IV (KOOS) | NS | NS | |
Yuen et al 29 | North America | 2009 | Retrospective case series | TL cavity: vascularized mastoid bone flap | 17 | 56.5 | 7 M:10 F | VS | 30 | NS | 12–15 mo |
TL cavity: fat packing | 10 | 51.3 | 6 M:4 F | VS | 28 | NS | 1 y+ | ||||
Charpiot et al 59 | Europe | 2009 | Retrospective case series | 123 | 46.4 | 62 M:61 F | VS | Stage IV KOOS | NS | 1 y+ | |
Wiet et al 39 | North America | 2000 | Retrospective case series | 44 | 57.8 | 21 M:23 F | VS | 19 | NS | NS | |
Khrais et al 33 | Europe | 2004 | Retrospective case series | 710 | 50.5 | 332 M:378 F | VS | 20 | NS | ||
Fishman et al 40 | North America | 2004 | Retrospective case series | 101 | NS | NS | VS | NS | NS | NS | |
Goddard et al 35 | North America | 2010 | Retrospective case series | 61 | 46.6 | 27 M:34 F | VS | 23 | NS | 31.3 mo | |
Bambakidis et al 50 | North America | 2010 | Retrospective case series | 15 | 53.5 | 7 M:8 F | VS | 12 a | NS | NS | |
Angeli et al 54 | Europe | 2011 | Retrospective case series | 110 | 42.5 | 51 M:59 F | VS | 41 | NS | 1 y+ | |
Netto et al 28 | South America | 2012 | Retrospective case series | Dural repair: fat plugging | 18 | 51.47 | 13 M: 21 F | VS | 23 | NS | 1 y+ |
Dural repair: synthetic dura + fat plugging | 16 | NS | NS | ||||||||
Ben Ammar et al 34 | Africa | 2012 | Retrospective case series | 1,865 | 50.39 | 886 M:979 F | VS | 18 | NS | 5.7 y | |
Liu et al 22 | North America | 2012 | Retrospective case series | Dural repair: fascial sling | 8 | 55.6 | 5 M:3 F | VS | NS | NS | 13.8 mo |
Dural repair: synthetic sling | 5 | 49.6 | 1 M:4 F | VS | NS | NS | 35.8 mo | ||||
Zhang et al 58 | Asia | 2012 | Retrospective case series | 115 | 46.42 | 50 M:65 F | VS | 40.7 | NS | 1 y+ | |
Manjila et al 47 | North America | 2013 | Retrospective case series | 42 | 50.5 | 21 M:21 F | VS | 15.1 | NS | NS | |
Boghani et al 45 | North America | 2013 | Retrospective case series | 13 | 51.9 b | 1 M:1.33 F b | VS | NS | NS | NS | |
Hunter et al 48 | North America | 2015 | Retrospective case series | 53 | 54 | 29 M:34 F | CPA tumors | 18.8 | 30.8 | 5.4 mo | |
Crowson et al 12 | North America | 2016 | Retrospective case series | Lumbar drain | 110 | 52.3 b | 1 M:1.33 F b | VS | 19.1 b | NS | NS |
North America | 2016 | Retrospective case series | No lumbar drain | 11 | 52.3 b | 1 M:1.33 F b | VS | 19.1 b | NS | NS | |
Volsky et al 36 | North America | 2017 | Retrospective case series | 369 | NS | NS | VS | NS | NS | Pittsburgh 5.2 y, Louisiana 577 d | |
Russel et al 55 | Europe | 2017 | Retrospective case series | 275 | 55.4 a | 122 M:153 F | VS | NS | 25.3 a | NS | |
Ölander et al 56 | Europe | 2018 | Retrospective case series | 700 | 53 | 330 M:370 F | VS | 27 | NS | NS | |
Luryi et al 30 | North America | 2020 | Retrospective case series | 52 | 56.2 | 27 M:25 F | VS 51, meningioma 1 | 22 | NS | 30.5 mo | |
Plainfossé et al 23 | Europe | 2022 | Retrospective case series | Without ET packing | 8 | 53.6 | 4.55 M:1 F b | VS | NS | 25.7 | 5.5 y |
Plainfossé et al 23 | Europe | 2022 | Retrospective case series | With ET packing | 39 | 53.6 | |||||
Cooper et al 42 | North America | 2021 | Retrospective case series | 23 | 57 | 9 M:14 F | VS | NS | NS | 21 mo | |
Totten et al 25 | North America | 2021 | Retrospective case series | Dural autograft | 56 | 49 | NS | VS = 54, FN schwannoma = 2 | 22 | 27.7 ( a ) | 15 mo a |
Dural xenograft | 21 | 47 | NS | VS = 18, epidermoid = 2, meningioma = 1 | 25 | 27.7 ( a ) | 14 mo a | ||||
Selleck et al 27 | North America | 2021 | Retrospective case series | TL cavity: fat only | 38 | 56.4 | 13 M:25 F | VS | 19.6 | 30.7 | 691 d |
TL cavity: fat + plate | 94 | 51 | 40 M:54 F | VS | 22 | 30.5 | 3,369 d | ||||
Martinez-Perez et al 24 | Europe | 2022 | Retrospective case series | Tl cavity: mastoid fat + HAC | 34 | 49.7 | 14 M:20 F | CPA tumors | NS | NS | NS |
Retrospective case series | TL cavity: mastoid fat | 35 | 50.7 | 17 M:18 F | NS | NS | NS | ||||
Sioshansi et al 20 | North America | 2021 | Retrospective case series | TL cavity: Fat Graft | 30 | 53.67 | 14 M:16 F | VS | 19.36 | 27.5 | 3 mo+ |
TL cavity: HAC | 33 | 54.8 | 13 M:17 F | VS | 20.6 | 28.9 | 3 mo + | ||||
Freeman et al 49 | North America | 2023 | Retrospective case series | 205 | 52.5 | 77 M:128 F | VS | 23 | 28.8 | NS | |
Christopher et al 26 | North America | 2021 | Retrospective case series with matched cohort analysis | Mastoid approach | 102 | 51 | 45 M: 57 F | VS | 24.1 | NS | NS |
Retrospective case series with matched cohort analysis | Facial recess approach | 102 | 49 | 48 M:54 F | VS | 24.2 | NS | NS |
Abbreviations: AAA, aditus ad antrum; BW, bone wax; CSF, cerebrospinal fluid; ET, eustachian tube; HAC, hydroxyapatite cement; LD, lumbar drain; ME, middle ear; NS, not specified; s/c, subcutaneous; TL, translabyrinthine; WT, watertight.
Median.
Value averaged from larger dataset.